BSYI — BioSyntech Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for BioSyntech, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2005 March 31st | 2006 March 31st | 2007 March 31st | R2008 March 31st | 2009 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.178 | 0.062 | 0.244 | 0.274 | 0.041 |
| Cost of Revenue | |||||
| Gross Profit | 0.098 | 0.041 | 0.154 | 0.172 | 0.025 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.32 | 6.92 | 8.36 | 9.54 | 13 |
| Operating Profit | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
| Net Income Before Taxes | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -5.14 | -6.85 | -8.11 | -9.27 | -12.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.142 | -0.167 | -0.086 | -0.097 | -0.116 |
| Dividends per Share |